Yasumichi Hitoshi

Activation of the PKB/AKT pathway by ICAM-2.

Shigemi Kinoshita, Garry P Nolan, James B Lorens, 2002, Immunity.

R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm.

Takuya Matsunaga, Gary Park, Wayne Lang, 2011, Blood.